-
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September.
-
The Biden administration may scrap plans to expand eligibility for second boosters to younger adults. Instead, it's trying to speed up the next generation of boosters targeting the omicron variant.
-
Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.
-
A 75-year-old woman became enmeshed in conspiracy theories about COVID. After she got infected, she rejected effective treatments and sought out black market drugs instead.
-
The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.
-
Nobody wants to infect their friends and friendly, but do you really have to keep isolating at day 12, 13 or beyond? Unfortunately — and perhaps unsurprisingly — the science is not entirely settled.
-
The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate to have an effective booster ready for fall of 2022, the company said.
-
Residents are urged to wear a mask indoors in public, stay up to date with COVID-19 vaccines and boosters, and get tested if they have symptoms.
-
People who catch COVID may feel as if they won't get it again, at least not for a long time. Their immune system should be primed to fight it off in the future. Right? Well, let's see.
-
Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection.